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Abstract
Background: Tuberculosis (TB) care can be costly for patients and their families. The End TB Strategy includes a
target that zero TB affected households should experience catastrophic costs associated with TB care. Costs are
catastrophic when a patient spends 20% or more of their annual household income on their TB diagnosis and care.
In Solomon Islands the costs of TB care are unknown. The aim of this study was to determine the costs of TB
diagnosis and care, the types of costs and the proportion of patients with catastrophic costs.
Methods: This was a nationally representative cross-sectional survey of TB patients carried out between 2017 and
2019. Patients were recruited from health care facilities, from all ten provinces in Solomon Islands. During an
interview they were asked about the costs of TB diagnosis and care. These data were analysed using descriptive
statistics to describe the costs overall and the proportions of different types of costs. The proportion of patients
with catastrophic costs was calculated and a multivariate logistic regression was undertaken to determine factors
associated with catastrophic costs.
Results: One hundred and eighty-three TB patients participated in the survey. They spent a mean of 716 USD (inter
quartile range: 348–1217 USD) on their TB diagnosis and care. Overall, 62.1% of costs were attributable to non-
medical costs, while income loss and medical costs comprised 28.5 and 9.4%, respectively. Overall, 19.7% (n = 36) of
patients used savings, borrowed money, or sold assets as a financial coping mechanism. Three patients (1.6%) had
health insurance. A total of 92.3% (95% CI: 88.5–96.2) experienced catastrophic costs, using the output approach.
Being in the first, second or third poorest wealth quintile was significantly associated with catastrophic costs
(adjusted odds ratio: 67.3, 95% CI: 15.86–489.74%, p < 0.001).
Conclusion: The costs of TB care are catastrophic for almost all patients in Solomon Islands. The provision of TB
specific social and financial protection measures from the National TB and Leprosy Programme may be needed in
the short term to ameliorate these costs. In the longer term, advancement of universal health coverage and other
social and financial protection measures should be pursued.
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Background
The costs of tuberculosis (TB) diagnosis and care are
thought to be a significant impediment to accessing health
care for patients, and to attaining national and global tar-
gets of reductions in TB incidence and mortality for na-
tional TB programmes [1]. Previous studies have
documented that TB patients often incur large costs related
to their illness, as well as seeking and receiving health care
[2, 3]. Such costs can create barriers to health care access
and treatment adherence, which can affect health outcomes
and increase the risk of TB transmission. These costs can
also be detrimental to the economic situation of households
as TB predominantly affects people of working age. By way
of example, in low-and middle-income countries, TB pa-
tients face costs that on average amount to half of their an-
nual income [2]. Lost income is often the dominant
contributor to economic hardship; however out-of-pocket
medical expenditures are also important [4–6]. In addition,
costs for travel, food and relocation during health seeking
are also significant, given the often long health seeking
period and the six-month to two-year period of TB treat-
ment that is the internationally accepted standard for treat-
ment to be effective [2]. In fact, a previous systematic
review determined that these costs are equivalent to 58% of
annual individual income and 39% of annual household in-
come, worse for people who were already poor or who had
multidrug-resistant (MDR)-TB [2].
The costs of TB diagnosis and care can be estimated
through national TB patient cost surveys using a meth-
odology designed by the World Health Organization
(WHO) [7]. Using this method, measurement of a range
of patient costs due to TB help to identify areas for im-
provement in TB service delivery and financing, and
contribute to the measurement of the End TB Strategy
indicator for the target that zero TB affected households
should experience catastrophic costs related to TB, to be
attained by the year 2020 [1]. Costs are said to be “cata-
strophic” when spending on TB is equal to or greater
than 20% of the TB patients’ annual household income
[1]. The results of such surveys are important to assess
the magnitude of patient costs and identify the main cat-
egories of costs, which can then be used to monitor fi-
nancial barriers to accessing and adhering to TB services
and inform related health and social policy changes to
improve TB care [8].
Solomon Islands is a medium burden TB country. It
reports approximately 400 TB case notifications per year,
resulting in a TB case notification rate of 62 cases per
100,000 population [9, 10]. A joint programme review of
the National TB and Leprosy Programme (NTLP) in
2019 identified multiple barriers for patients in accessing
TB services along their care pathways. TB patients often
present late for a TB diagnosis, mainly due to a lack of
awareness about TB, and difficult access to health
facilities due to the country’s geography and lack of pub-
lic transport [11]. Health centres also lack laboratory
and human resource capacity to diagnose and initiate
TB treatment, so they often refer patients to a provincial
hospital [11]. If the patient is diagnosed with TB, histor-
ically they have been hospitalized for two months and
then after this, they are discharged and receive treatment
closer to their home [11]. However, the real costs of TB
care are unknown in Solomon Islands.
Therefore, this study aimed to conduct a baseline as-
sessment of the economic burden of TB on patients and
their households in Solomon Islands, using the WHO
recommended national TB patient survey methodology,
something that was also recommended during the 2019
programme review [11]. The specific aims were to deter-
mine the financial burden of TB for patients in Solomon
Islands and to inform policies to mitigate costs and im-
prove access to TB care.
Methods
Setting
Solomon Islands is comprised of over 900 islands and is
located in the Pacific Ocean [12]. It has a population of
approximately 640,000 people, of whom 80% live in rural
areas [12, 13]. It is a lower middle income country [9]
where 12.7% of the population live below the national
poverty line [14]. Health care in Solomon Islands is
largely provided by the public sector and out-of-pocket
spending on health is low [15]. However, non-medical
expenditures, particularly for transportation to access
health care, are reported to be high [16, 17]. The Solo-
mon Islands NTLP is based in Honiara (the capital).
Then, in all ten provinces, there is a designated health
facility or hospital that serves as a TB Directly Observed
Treatment Short-course (DOTS) centre, which is staffed
by a Provincial Tuberculosis and Leprosy Coordinator. It
provides TB services and serves as a TB Basic Manage-
ment Unit for that province. The country has been
implementing the World Health Organization (WHO)
recommended strategy for controlling TB, which evolved
from the DOTS strategy, the Stop TB strategy and cur-
rently the End TB Strategy. For the past decades, the
NTLP has made good progress against a number of
programmatic indicators [11]. For example, the treat-
ment coverage and treatment success rates in 2017
were 80 and 92% respectively and the proportion of
TB patients who were bacteriologically confirmed in
2018 was 65% [11]. However, various challenges re-
main; including; access barriers, limited implementa-
tion planning across all levels of the health system,
resource constraints which limit outreach services and
inconsistent use of preventive therapy in eligible risk
groups [11].
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Study design
This was cross-sectional survey of TB patients including
all ten DOTS centres offering TB treatment in the coun-
try, and therefore a nationally representative study that
aimed to assess the costs associated with TB diagnosis
and care.
Sampling approach and study population
The sample size was estimated at 228 patients. This fig-
ure was based on the number of DOTS centres offering
TB treatment (n = 10), and the number of patients diag-
nosed in Solomon Islands per year (at the time of proto-
col development in 2016, this was n = 360), assuming a
level of 30% catastrophic costs and a 5% non-
participation rate. At the time, 30% was deemed a rea-
sonable estimate given the pre existing knowledge on
this topic [2]. The study population consisted of all diag-
nosed TB patients (of all ages and with all types of TB)
who had received TB treatment for at least two weeks
whether they were in the intensive phase or the continu-
ation phase, from the selected DOTS centres.
Questionnaire
The WHO have developed a standardised, structured
questionnaire for TB patient cost surveys which was
adapted to the Solomon Islands context (Add-
itional file 1). The questionnaire contained information
on clinical parameters; demographic variables and
household composition; socioeconomic variables; health
care utilisation; time spent seeking and receiving care;
direct medical, direct non-medical and indirect costs;
household and individual income; household assets; fi-
nancial and social coping mechanisms and the perceived
impacts of costs. The questionnaire contained closed
and open-ended questions. It was pilot tested and fur-
ther refined after a two-day national training on data
collection methods and interview techniques. The ques-
tionnaire was uploaded into Open Data Kit collect
within the Ona platform (https://ona.io/home/), and was
designed with built-in options and skips to promote ac-
curate data collection.
Patient interviews
Interviewers were trained Provincial TB and Leprosy
Co-ordinators or other NTLP staff (i.e. health care
workers). They approached TB patients to be involved in
the study as they attended clinic visits. Interviews took
place at the clinic or during follow up home visits in a
separate space or outside, to allow for privacy and to en-
sure optimal infection control practices. All patients
interviewed were on effective treatment for more than
two weeks prior to the interview, and as such the infec-
tion risk was minimal. Interviewers read the questions to
TB patients in Solomon Islands Pigin (the lingua franca
in Solomon Islands), and recorded responses directly
into a tablet. For children aged under 18 years, an ac-
companying parent or guardian answered the questions.
The interviews took 60–90min to complete.
Data collection and management
Data were collected between 2017 and 2019. Once the
interview was finished, interviewers submitted the data
in the Ona platform; data were then sent directly to a
password protected server, also in Ona. A small number
of questionnaires were completed on a paper version (a
direct replication of the electronic version); these were
then sent to the NTLP Co-ordinator who entered them
into Ona. During the period of data collection, remote
checks of the data were undertaken by the survey inves-
tigators; any obvious or repetitive errors were fed back
to the NTLP Co-ordinator and the interviewers. Then,
in December 2019, during a Provincial TB and Leprosy
Co-ordinator training, each record was checked by an
experienced external consultant and any errors were
corrected (T Yamanaka, personal communication, July
2020).
Definitions and data analysis
Direct medical costs were defined as “out-of-pocket pay-
ments made by TB-affected patients or their guardians
for medical services (i.e. consultations, tests, medicines,
other medical procedures), net of any reimbursements”
while direct non-medical costs were defined as “out-of-
pocket payments made by TB-affected patients or guard-
ians related to transportation, accommodation, food, nu-
tritional supplements”, net of any reimbursements [7].
Indirect costs were “productivity and economic costs of
a TB patient or someone in their household incurred as
a result of TB health care visits and hospitalization dur-
ing the TB episode.” [7]. Catastrophic costs were defined
as the sum of direct medical, direct non-medical and in-
direct costs, net of any welfare payment that exceeded
20% of the household’s income [1].
Annual household income was estimated using two
approaches. An adjusted approach was added as Solo-
mon Islands has a large informal and cash based econ-
omy [7]. Using the output approach, indirect costs were
measured using “self-reported household income at
three points in time (prior to the onset of TB symptoms,
at the time of diagnosis and during the current treat-
ment phase) to estimate income change before and dur-
ing the TB episode.” [7]. For households without income
information, it was imputed using a regression model
based on household assets information. Using a second
(adjusted) approach, household income was adjusted to
account for the proportion of the population with non-
cash based income, using the results from the most re-
cent Solomon Islands Household Income Expenditure
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Survey (HIES); completed in 2013 [18]. The results of
the HIES revealed that cash-based income accounted for
63% of total annual income, and this proportion was
considerably lower in rural areas and for poor house-
holds [18]. Self-reported household income was then ad-
justed using the following method:
1. the reported household income was assumed to be
“cash-based” income;
2. for those who did not have household income
information, it was imputed based on household
assets;
3. HIES income decile groups were applied to
reported household income (Supplementary
Table 1);
4. household cash-based income was divided by the
proportion of households with cash- based income
observed in the HIES (by decile).
All analyses were carried out using the statistical
software package R 4.0.2 (CRAN:Comprehensive
RArchive Network at https://cran.r-project.org/). R
scripts prepared by the Global TB Programme, WHO,
were used as the basis for analyses with modifications
for the analytical approach. The study population was
described using descriptive statistics with mean or
median values used as appropriate. Median medical,
non-medical costs and indirect costs, before TB treat-
ment started and during TB treatment were calcu-
lated. Medical, non-medical and indirect costs as a
proportion of all costs were also determined, as was
the proportion of TB patients who incurred cata-
strophic costs. To estimate the costs of TB care for
the entire period of TB diagnosis and care, we im-
puted costs based on data from patients in a certain
treatment phase (i.e. intensive or continuation phase).
This is the approach recommended by WHO, where
missing cost data for a particular phase of TB treat-
ment are replaced by the median values obtained
from other survey participants in the same phase. Pa-
tients with pulmonary TB and extra-pulmonary TB
were compared using the chi-square test for categor-
ical data and the Welsh T-test or two-sample Wil-
coxon rank-sum test for continuous data. Finally, a
stepwise multivariate regression analysis was under-
taken to determine which binary variables were inde-
pendently associated with catastrophic costs. We used
the adjusted household income for the regression ana-
lysis, as the proportion of patients with catastrophic
costs was lower (i.e. it was more conservative). Ad-
justed odds ratios with their associated 95% confi-
dence intervals (CIs) and p values were presented.
Measures of association were considered significant at
the 5% significance level.
Results
Demographic and clinical characteristics
A total of 183 TB patients participated in the survey; 147
(80.3%) had pulmonary TB (PTB) and 36 (19.7%) had
extra-pulmonary TB (EPTB) (Table 1). There were no
statistically significant differences between patients with
EPTB and PTB except for the year of TB registration
and province of residence (p = 0.036 and 0.028, respect-
ively). Ninety-two (50.3%) patients were male and the
mean age was 32.8 years (95% CI: 30.3–35.2). Only 23
(12.6%) reported being employed before their TB diag-
nosis and overall, the median monthly household in-
come was USD 22.2 (inter-quartile range (IQR) 12.3–
91.1) or 180.0 Solomon Island dollars (IQR 100.0–
740.0)). All patients were being treated for drug suscep-
tible TB, 97 (53.0%) were in the intensive phase, and 95
(51.9%) were hospitalized at the time of interview
(Table 2). The only statistically significant differences
when comparing the clinical characteristics of patients
with EPTB and PTB were the proportion of patients
who were bacteriologically confirmed (13.9% vs 78.9%,
p < 0.001, for EPTB and PTB respectively) and the mean
duration of the intensive phase (2.3 months vs. 2.1
months, p = 0.048, for EPTB and PTB, respectively).
Fifty-three percent (n = 44) patients reported a diagnos-
tic delay (defined as an interval between onset of symp-
toms and a TB diagnosis of four weeks or more)
(Supplementary Table 2).
Time lost for care seeking and treatment
Patients lost a mean of 354.4 working hours (95%CI:
287.3, 421.4). Additionally, the household lost a mean of
105.7 working hours (95%CI: 33.1, 178.3) for TB care
seeking and treatment (Table 3). Patients with EPTB lost
more time compared to PTB patients (490.7 h for EPTB
and 321.0 h for PTB, p = 0.047) due to a significantly
longer time for hospitalization (463.7 h for EPTB versus
292.3 h for PTB, p = 0.041).
Estimated total costs incurred by TB patients and their
households and proportion of TB-affected households
experiencing catastrophic costs (using the output
method)
The median cost of a TB diagnosis and care was USD
716 (IQR: 349–1247), equivalent to 8.8 times the re-
ported monthly household income (Table 4). The costs
were driven by direct non-medical costs (62.1%), income
loss (28.5%), and direct medical costs (9.4%) (Fig. 1).
Costs for nutritional supplements other than the pa-
tients’ regular diet accounted for the highest proportion
of direct non-medical costs (27.3% of all costs) followed
by food costs (12.1%), travel costs (11.9%) and accom-
modation (8.3%). Direct medical costs were predomin-
antly incurred after diagnosis and were driven by costs
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Table 1 Socio-demographic characteristics of patients who participated in the Solomon Islands national tuberculosis patient cost
survey: 2017–2019











0–14 3 (8.3) 18 (12.2) 21 (11.5) 0.964
15–24 10 (27.8) 31 (21.1) 41 (22.4)
25–34 8 (22.2) 32 (21.8) 40 (21.9)
35–44 8 (22.2) 30 (20.4) 38 (20.8)
45–54 4 (11.1) 20 (13.6) 24 (13.1)
55–64 2 (5.6) 9 (6.1) 11 (6.0)
65+ 1 (2.8) 7 (4.8) 8 (4.4)
Mean (95% CI) 31.8 (26.4, 37.2) 33.0 (30.2, 35.8) 32.8 (30.3, 35.2) 0.700
Sex
Female 19 (52.8) 72 (49.0) 91 (49.7) 0.683
Male 17 (47.2) 75 (51.0) 92 (50.3)
Year of TB registration
2017 0 (0.0) 13 (8.8) 13 (7.1) 0.036
2018 20 (55.6) 95 (64.6) 115 (62.8)
2019 16 (44.4) 39 (26.5) 55 (30.1)
Province
Central 1 (2.8) 4 (2.7) 5 (2.7) 0.028
Choiseul 0 (0.0) 5 (3.4) 5 (2.7)
Guadalcanal 7 (19.4) 15 (10.2) 22 (12.0)
Honiara City 16 (44.4) 35 (23.8) 51 (27.9)
Makira 2 (5.6) 21 (14.3) 23 (12.6)
Malaita 10 (27.8) 36 (24.5) 46 (25.1)
Temotu 0 (0.0) 11 (7.5) 11 (6.0)
Western 0 (0.0) 19 (12.9) 19 (10.4)
Ysabel 0 (0.0) 1 (0.7) 1 (0.5)
Insurance status
No insurance 36 (100.0) 144 (98.0) 180 (98.4) 0.387
With insurance 0 (0.0) 3 (2.0) 3 (1.6)
Education level
No education 9 (25.7) 23 (15.6) 32 (17.6) 0.560
Pre- or primary school 16 (45.7) 75 (51.0) 91 (50.0)
Secondary school 8 (22.9) 41 (27.9) 49 (26.9)
University, vocational or other 2 (5.7) 8 (5.4) 10 (5.5)
Employment status, pre-disease
Employed 7 (19.4) 16 (10.9) 23 (12.6) 0.265
Unemployed 14 (38.9) 75 (51.0) 89 (48.6)
Student, retired, household work or other 15 (41.7) 56 (38.1) 71 (38.8)
Household size
Mean (95% CI) 6.7 (5.7, 7.7) 6.7 (6.3, 7.2) 6.7 (6.3, 7.1) 0.970
Reported household income, monthly, pre-disease, monthly
Median (IQR) 12.3 (0.0, 87.4) 24.6 (12.3, 92.4) 22.2 (12.3, 91.1) 0.252
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associated with hospitalization. There were statistically
significant differences observed in the costs of direct
medical costs before diagnosis (p = 0.033), transport dur-
ing TB treatment (p < 0.001), food during TB treatment
(p = 0.039), total direct non-medical costs (p = 0.044)
and direct medical costs (p = 0.042) when comparing pa-
tients with EPTB and PTB. In all cases, the costs were
higher for patients with EPTB, compared to patients
with PTB.
The proportion of TB-affected households experien-
cing catastrophic costs was 92.3% (95%CI: 88.5–96.2%)
using the output approach. When only direct costs were
included (which accounted for 71.5% of total TB patient
costs overall), 81.4% of TB-affected households incurred
catastrophic costs. When the catastrophic costs thresh-
old was changed (in a range from 10 to 60%, using the
output approach), the proportion of patients incurring
catastrophic costs ranged from 78.1 to 95.1% (Supple-
mentary Table 3).
Influence of adjustment for cash-based household income
on estimated total costs incurred by TB patients and their
households and proportion of TB-affected households
experiencing catastrophic costs
We also estimated income and therefore the proportion
of patients with catastrophic costs taking into account
the reported household income observed in this survey
and the household income decile recorded in the Solo-
mon Islands HIES. Using this approach 171 (93.4%) pa-
tients were classified in the poorest wealth decile. The
remainder were categorized as being in the second to
fourth wealth decile groups, with no households classi-
fied in the fifth to tenth deciles (Supplementary Table 4).
The adjusted mean monthly household income was then
estimated at USD 367.9 (95%CI: 298.6–437.3) and the
median cost of TB care was USD 1193 (IQR: 532–2346),
with a corresponding increase in income loss to USD
312 (IQR: 0–1247). This was equivalent to 3.2 times the
adjusted monthly household income and 14.6 times the
reported median monthly household income (based on
the survey responses). Costs were higher among patients
with EPTB (USD 1202; IQR: 727–2777) than patients
with PTB (USD 1107; IQR: 521–2241, p = 0.195) (Sup-
plementary Table 5). Using the adjusted household in-
come, the proportion of direct non-medical costs was
48.1% (versus 62.1% using the output method), while the
proportion of income loss increased from 28.5 to 45.4%,
and the proportion of direct medical costs was 6.4%,
compared 9.4% using the output method. Then, the pro-
portion of TB-affected households facing catastrophic
costs was 82.0% (95%CI: 76.3–87.6%; 86.1% (95%CI:
74.2–98.0%) for patients with EPTB, and 81.0% (95%CI:
74.5–87.4%) for patients with PTB).
Factors associated with catastrophic costs due to TB
In multivariate analyses, where we used the adjusted
household income, being poorer was significantly associ-
ated with having catastrophic costs due to TB (Table 5).
96.9% of TB affected households classified as being in
the first (poorest), second or third poorest quintiles
faced catastrophic costs, and they had 67.3 times higher
odds of experiencing catastrophic costs compared with
the wealthiest households (95% CI: 15.86–489.74, p <
0.001).
Reported coping mechanism and social consequences
Overall, 19.7% (n = 36) of TB-affected households used
their savings, borrowed money, or sold their assets as fi-
nancial coping mechanisms (Table 6). One quarter
(24.6%, n = 45) experienced food insecurity, 21.3% (n =
39) interrupted schooling, and 8.2% lost their job (n =
15). In terms of perceived financial impact due to TB,
83.7% (n = 153) reported that TB had a moderate to very
serious financial impact on their households (moderate:
37.2%, serious: 35.0%, very serious: 11.5%; these categor-
ies of severity were self reported by patients). Only 4.9%
(n = 9) received social support either from family or rela-
tives (n = 7) or from the Parliament (n = 2). In addition,
36.1% (n = 66) received vouchers in the form of food
support (n = 63), a travel voucher (n = 1), or via an un-
known source (n = 2). There were no statistically signifi-
cant differences observed between patients with EPTB
Table 1 Socio-demographic characteristics of patients who participated in the Solomon Islands national tuberculosis patient cost
survey: 2017–2019 (Continued)










TB patient was main income earner
Yes 1 (2.8) 8 (5.4) 9 (4.9) 0.694
No 14 (38.9) 66 (44.9) 80 (43.7)
Equal contributor 13 (36.1) 40 (27.2) 53 (29.0)
Not an income earner 8 (22.2) 33 (22.4) 41 (22.4)
Abbreviations: CI Confidence interval; IQR Inter quartile range; TB Tuberculosis.* P values compare the proportions of patients with the characteristic of interest, in
the pulmonary and extra-pulmonary groups
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Table 2 Clinical information of patients who participated in the Solomon Islands national tuberculosis patient cost survey: 2017–
2019











New 34 (94.4) 136 (92.5) 170 (92.9) 0.917
Relapse 1 (2.8) 5 (3.4) 6 (3.3)
Retreatment excluding relapse 1 (2.8) 6 (4.1) 7 (3.8)
Drug resistance status
Drug susceptible-TB 36 (100.0) 147 (100.0) 183 (100.0) –
HIV status
Negative 24 (66.7) 92 (62.6) 116 (63.4) 0.813
Positive 0 (0.0) 1 (0.7) 1 (0.5)
Unknown 12 (33.3) 54 (36.7) 66 (36.1)
Drug susceptibility testing conducted
DST done 0 (0.0) 2 (1.4) 2 (1.1) 0.482
DST not done 36 (100.0) 145 (98.6) 181 (98.9)
Mode of TB diagnosis
Bacteriologically confirmed 5 (13.9) 116 (78.9) 121 (66.1) < 0.001
Clinically diagnosed 31 (86.1) 31 (21.1) 62 (33.9)
Treatment phase
Intensive phase 21 (58.3) 76 (51.7) 97 (53.0) 0.475
Continuation phase 15 (41.7) 71 (48.3) 86 (47.0)
Duration of intensive phase (months, mean (95% CI)) 2.3 (2.0, 2.5) 2.1 (2.0, 2.2) 2.1 (2.1, 2.2) 0.048
Duration of continuation phase (months, mean (95% CI)) 5.1 (4.8, 5.5) 4.8 (4.6, 5.0) 4.9 (4.7, 5.0) 0.054
Treatment facility
Government primary health care facility 4 (11.1) 15 (10.2) 19 (10.4) 0.126
Government hospital 31 (86.1) 105 (71.4) 136 (74.3)
Faith based health center or hospital 0 (0.0) 15 (10.2) 15 (8.2)
Other 1 (2.8) 12 (8.2) 13 (7.1)
Mode of supervision for TB treatment: intensive phase
Hospitalized 21 (100.0) 72 (94.7) 93 (95.9) 0.562
Self-administered 0 (0.0) 2 (2.6) 2 (2.1)
Unknown 0 (0.0) 2 (2.6) 2 (2.1)
Mode of supervision for TB treatment: continuation phase
Hospitalized 0 (0.0) 2 (2.8) 2 (2.3) 0.609
Self-administered 13 (86.7) 57 (80.3) 70 (81.4)
Community-based DOT 1 (6.7) 10 (14.1) 11 (12.8)
Facility-based DOT 1 (6.7) 1 (1.4) 2 (2.3)
Unknown 0 (0.0) 1 (1.4) 1 (1.2)
Currently hospitalized
No 15 (41.7) 73 (49.7) 88 (48.1) 0.390
Yes 21 (58.3) 74 (50.3) 95 (51.9)
Previously hospitalized in the current phase
No 30 (83.3) 117 (79.6) 147 (80.3) 0.613
Yes 6 (16.7) 30 (20.4) 36 (19.7)
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or PTB for coping mechanisms, social consequences, so-
cial support or receipt of vouchers.
Discussion
This survey identified that the cost of TB care is cata-
strophic for almost all TB-affected households in Solo-
mon Islands (92.3%, or 82.0%, adjusted) as the median
cost of TB care was equivalent to 8.8 times the monthly
household income. Only 5 % of patients received social
support during their TB care, only 2 % of patients had
health insurance and one in five used their savings, bor-
rowed money, or sold their assets to cope with the eco-
nomic burden of TB.
The global TB report published by WHO in 2020 pro-
vides an overview of the results of other TB patient cost
surveys to compare to the results observed in Solomon
Islands [19]. By July 2019, 17 countries had completed a
national TB patient cost survey [19]. In these countries,
the percentage of TB-affected households who experi-
enced catastrophic costs ranged from 19% (95%CI: 15–
25%) in Lesotho to 83% (95%CI: 76–86) in Timor-Leste
[19, 20]. Overall, the pooled average of catastrophic costs
was 49% (95%CI: 34–63) [19]. The figure observed in
Solomon Islands is higher than the figures reported in
all of these countries.
The high proportion of direct non-medical costs in
Solomon Islands (62.1% of all costs) was largely driven
by nutritional supplements (corresponding to the largest
group of non-medical costs, at 27.3% of all costs). A
similar observation was made in the Timor-Leste na-
tional TB patient cost survey, and in other surveys [20–
22]. Malnutrition is a known risk factor for TB [10] and
weight loss is a well-documented symptom of TB [23].
Therefore there may be some groups of patients who are
malnourished or underweight at TB diagnosis who seek
to use nutritional supplements to recover. However, it is
not clear what nutritional supplements are being bought
by TB patients, if they have been recommended by
health care workers, or if there are other local beliefs
about the effect of certain nutritional supplements on
health. The proportion of patients who are malnourished
or who are underweight at TB diagnosis is also unknown
in the Solomon Islands context. These issues require
further investigation.
Table 2 Clinical information of patients who participated in the Solomon Islands national tuberculosis patient cost survey: 2017–
2019 (Continued)










Number of days hospitalized in the current phase, mean (95% CI) 41.6 (33.6, 49.5) 43.6 (39.6, 47.7) 43.2 (39.7, 46.8) 0.647
Abbreviations: DOT Directly observed therapy; DST Drug susceptibility testing; DS TB Drug susceptible TB; EPTB Extra pulmonary TB; PTB Pulmonary TB; TB
Tuberculosis. * P values compare the proportions of patients with the characteristic of interest, in the pulmonary and extra-pulmonary groups
Table 3 Mean number of working hours lost for tuberculosis care for patients and their households in the Solomon Islands national
tuberculosis patient cost survey: 2017–2019
Amount of lost time Extra-pulmonary TB
N = 36
Mean no. of hours (95% CI)
Pulmonary TB
N = 147
Mean no. of hours (95% CI)
All patients
N = 183
Mean no. of hours (95% CI)
p value
For TB care for TB patients
Pre-disease 6.8 (2.0, 11.5) 7.3 (3.7, 11.0) 7.2 (4.2, 10.2) 0.875
Hospitalization 463.7 (295.7, 631.7) 292.3 (221.2, 363.3) 326.0 (260.0, 392.0) 0.041
Directly observed therapy 3.4 (−1.6, 8.3) 11.5 (−0.4, 23.5) 9.9 (0.3, 19.6) 0.508
Drug pick-up 15.0 (−2.6, 32.7) 8.2 (6.0, 10.3) 9.5 (5.7, 13.3) 0.152
Follow-up 3.8 (0.8, 6.8) 4.2 (2.0, 6.4) 4.1 (2.2, 6.0) 0.877
Total lost time 490.7 (320.6, 660.9) 321.0 (248.6, 393.4) 354.4 (287.3, 421.4) 0.047
For TB care for household members of TB patients*
Hospitalization 103.2 (−5.8, 212.2) 227.3 (13.3, 441.2) 198.5 (33.3, 363.7) 0.531
Directly observed therapy 0.0 (0.0, 0.0) 15.1 (−7.0, 37.3) 12.4 (−5.7, 30.6) 0.531
Drug pick-up 28.5 (−19.2, 76.1) 8.5 (4.6, 12.5) 11.9 (3.9, 19.9) 0.065
Follow-up 1.2 (−0.1, 2.5) 3.8 (1.0, 6.6) 3.2 (1.1, 5.4) 0.312
Total lost time 63.4 (9.6, 117.2) 117.6 (25.6, 209.5) 105.7 (33.1, 178.3) 0.544
Abbreviations: CI Confidence interval; no number; TB Tuberculosis.* This is in addition to the TB patient
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Travel, food and accommodation costs were also con-
siderable, accounting for 32.3% of all costs, which may
be attributable to the fact that the people travel (often
long distances) to get to one of the DOTS centres for a
TB diagnosis. TB care is offered in one DOTS centre per
province and the country is very geographically dis-
persed. Therefore patients and their families may travel
long distances from their home village to the nearest
DOTS centre to seek a TB diagnosis. If they are diag-
nosed, then the current national policy is that they are
hospitalised for the first two months of TB care (i.e. the
intensive phase). This is reflected in our results where
approximately half (51.9%) of patients were hospitalised
at the time of interview and one in five patients (19.7%)
had been previously hospitalised. The Ministry of Health
and Medical Services is currently considering options to
introduce community based and ambulatory treatment.
Income loss accounted for 28.5% of all costs and 8.2%
of people lost their job while receiving TB care. Loss of
employment and income loss are major barriers faced by
many TB patients, [22, 24, 25] with the stigma around
TB and misunderstandings about infectiousness as
potential contributing factors. These income losses
can be compensated for by social or financial protec-
tion schemes in many countries. However, these kinds
of schemes are generally not available in the Solomon
Islands. Voluntary health insurance is also generally
not available with the exception of schemes for expa-
triates [15].
Strengths and limitations
This is the first survey on the costs associated with TB
diagnosis and care in Solomon Islands. The survey pro-
vided baseline information including information on
health seeking behaviour, the costs of health care and
the drivers of these costs; these data can be used for fur-
ther monitoring of the End TB Strategy indicator and for
national planning. The survey investigators also demon-
strated that collecting data using online tools is feasible
in the Solomon Islands context and data completeness
was attained for many variables. In addition, the survey
is nationally representative, including all ten DOTS cen-
tres, which is not always easy in geographically dispersed
countries such as the Solomon Islands.
Table 4 Estimated median costs (USD) incurred by tuberculosis affected households in the Solomon Islands tuberculosis patient
cost survey: 2017–2019
Cost category Extra-pulmonary TB
N = 36
Median (IQR) in USD
Pulmonary TB
N = 147
Median (IQR) in USD
All patients
N = 183
Median (IQR) in USD
p value
Before TB diagnosis
Direct medical 0 (0, 0) 0 (0, 0) 0 (0, 0) 0.033
Direct non-medical 6 (5, 10) 6 (4, 6) 6 (4, 6) 0.577
Total direct before diagnosis 6 (5, 10) 6 (4, 6) 6 (5, 6) 0.706
During TB treatment: direct medical
Drug pickup 0 (0, 0) 0 (0, 0) 0 (0, 0) 0.776
Directly observed therapy 0 (0, 0) 0 (0, 0) 0 (0, 0) 0.675
Follow up 0 (0, 0) 0 (0, 0) 0 (0, 0) 0.843
Hospitalization 58 (0, 75) 33 (0, 62) 36 (0, 68) 0.181
Total direct medical during treatment 58 (0, 76) 36 (0, 69) 37 (0, 71) 0.260
During TB treatment: direct non-medical
Transportation 76 (65, 167) 30 (10, 107) 46 (13, 123) < 0.001
Accommodation 58 (0, 72) 31 (0, 59) 32 (0, 65) 0.109
Food during visits 75 (59, 160) 49 (11, 134) 64 (15, 142) 0.039
Nutritional supplement 320 (0, 880) 64 (0, 427) 85 (0, 427) 0.097
Total direct non-medical 501 (212, 1323) 395 (122, 826) 435 (146, 961) 0.046
Total
Direct medical 58 (0, 76) 36 (0, 70) 38 (0, 73) 0.292
Direct non-medical 509 (218, 1330) 390 (113, 846) 435 (141, 961) 0.042
Total direct 630 (271, 1390) 486 (165, 989) 494 (189, 1110) 0.044
Income loss 99 (0, 258) 74 (0, 333) 74 (0, 296) 0.500
Grand total 779 (427, 2302) 693 (343, 1207) 716 (349, 1247) 0.107
Abbreviations: IQR Inter quartile range; EPTB Extra pulmonary TB; PTB Pulmonary TB; USD United States Dollars; TB Tuberculosis
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This survey also has some limitations. First, the survey
investigators originally intended to recruit patients from
April to November 2016 and had developed a sampling
strategy that included a representative sample from all
provinces in the Solomon Islands, whereas, in practice,
the period of recruitment ran over three years (2017–
2019). However, a comparison of some of the key demo-
graphic characteristics in the sample was undertaken
and these were compared to the 2018 national TB sur-
veillance data. There were no statistically significant dif-
ferences in these variables when comparing the two
populations (T. Yamanaka, personal communication,
2020). Second, this was a cross-sectional survey with for-
ward extrapolations on patient costs. While this is a
practical method given the context of the study and is
recommended by WHO, the estimated costs may not re-
flect the true costs experiences by the patients due to
the illness. Longitudinal methods of determining patient
costs are accurate but may be more accurate. Third, re-
call bias is a concern when recalling costs incurred in
the past. As much as possible the interviewers used
prompts to assist patients in recalling costs, but it is
possible that the recollected numbers may have been in-
accurate. Fourth, the survey did not reach the estimated
sample size, but it was planned on notifications in previ-
ous years and then there were relatively small numbers
of patients in the participating DOTS centres, a common
challenge in countries with a lower TB case load and
where the number of TB patients may fluctuate over
time. As well, we recalculated the sample size based on
our finding that the proportion of patients with cata-
strophic costs in Solomon Islands was 92.3%. Using this
figure and the other sample size parameters described in
our Methods section, we would have required a sample
size of 126 TB patients. Therefore our sample size of
183 TB patients was sufficient even though it fell short
of our original estimated sample size. Then, we used an
estimate of 30% of catastrophic costs to estimate our
sample size, which was an under estimate. However
using a higher estimate would have resulted in a smaller
sample size, so we did not under sample in our study
and as more catastrophic cost surveys have been con-
ducted now it may be more feasible to provide an esti-
mate of the patients with catastrophic costs. Lastly, self-
Fig. 1 Categories of costs as a proportion of all costs associated with a tuberculosis diagnosis and care from the Solomon Islands national
tuberculosis patient cost survey: 2017–2019 (based on mean values)
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reported income was used as the measure of income in
this survey. Other methods of reporting or estimating in-
come - such as household consumption/ expenditure -
may be more accurate in settings such as Solomon
Islands where the majority of the population are
employed in the informal employment sector. Therefore,
the proportion of patients with catastrophic costs may
have been overestimated in this survey, which is consist-
ent with the fact that only 11.5% of people thought that
TB had a very severe financial impact on them. Future
methodological work on measuring income may deter-
mine which approach is preferred [26].
Public health implications
The findings from this survey highlight some of the diffi-
culties that patients in Solomon Islands experience when
accessing TB care. These findings are informative for
policy makers as they consider how they can improve
Table 5 Risk factors associated with catastrophic costs due to tuberculosis from the Solomon Islands national tuberculosis patient
cost survey: 2017–2019




Age group (years) 0–14 21 16 (76.2) Referent –
15–24 41 34 (82.9) 1.52 (0.40–5.52, p = 0.527) 1.80 (0.21–15.57, p = 0.587)
25–34 40 30 (75.0) 0.94 (0.26–3.14, p = 0.918) 1.04 (0.15–6.89, p = 0.966)
35–44 38 31 (81.6) 1.38 (0.36–5.05, p = 0.623) 1.04 (0.15–6.83, p = 0.964)
45–54 24 22 (91.7) 3.44 (0.65–26.19, p = 0.170) 1.59 (0.16–19.20, p = 0.694)
55+ 19 17 (89.5) 2.66 (0.49–20.44, p = 0.281) 0.79 (0.08–8.97, p = 0.839)
Sex Female 91 73 (80.2) Referent –
Male 92 77 (83.7) 1.27 (0.59–2.73, p = 0.541) 2.81 (0.91–9.59, p = 0.082)
Type of disease EPTB 36 31 (86.1) Referent –
PTB 147 119
(81.0)
0.69 (0.22–1.79, p = 0.473) 0.41 (0.08–1.69, p = 0.241)
Income quintile Wealthiest 48 21 (43.8) Referent –
Fourth 38 35 (92.1) 15.00 (4.60–68.37, p < 0.001) 17.66 (4.81–94.42, p < 0.001)
Poorest, second or third 97 94 (96.9) 40.29 (12.77–180.20, p <
0.001)
67.25 (15.86–489.74, p <
0.001)
Household size (no. of
persons)
0–7 91 75 (82.4) Referent –
8 or more 92 75 (81.5) 0.94 (0.44–2.01, p = 0.875) –
Education level University, vocational or other 10 6 (60.0) Referent –
Secondary school 49 35 (71.4) 1.67 (0.38–6.77, p = 0.477) 2.37 (0.30–19.05, p = 0.408)




5.19 (1.21–20.55, p = 0.020) 5.18 (0.69–38.16, p = 0.102)
Type of health facility Government primary health care facility 19 17 (89.5) Referent –
Government hospital 136 108
(79.4)
0.45 (0.07–1.71, p = 0.309) –
Faith based health center or hospital 15 13 (86.7) 0.76 (0.08–7.07, p = 0.801) –
Other 13 12 (92.3) 1.41 (0.12–32.44, p = 0.788) –
TB treatment phase Intensive phase 97 83 (85.6) Referent –
Continuation phase 86 67 (77.9) 0.59 (0.27–1.27, p = 0.181) 0.27 (0.02–4.05, p = 0.319)
Hospitalized in current phase No 147 122
(83.0)
Referent –
Yes 36 28 (77.8) 0.72 (0.30–1.85, p = 0.467) –
Hospitalized at time of
interview
No 88 68 (77.3) Referent –
Yes 95 82 (86.3) 1.86 (0.87–4.08, p = 0.115) 0.70 (0.05–10.76, p = 0.783)
Delay before diagnosis No 39 35 (89.7) Referent –
Yes 44 37 (84.1) 0.60 (0.15–2.18, p = 0.452) –
Abbreviations: CI Confidence interval; OR Odds ratio
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and expand universal health coverage in the Solomon
Islands. One obvious policy relevant finding is the cost
of accessing TB care in Solomon Islands and the need to
mitigate these costs of care, where possible. Mitigation
strategies may include the provision of vouchers or sub-
sidies for TB patients that could be provided by the
NTLP in the absence of wider social or financial protec-
tion schemes, which are currently limited in the Solo-
mon Islands [27]. Recently, the Solomon Islands
Government has adopted universal health coverage as
the principle of health system design and a role delinea-
tion policy is the major vehicle to achieve it [11]. This
policy defines a service delivery package and ensures
minimum services at the lowest level of health services
close to the community [11]. In the years to come, uni-
versal health coverage rollout in Solomon Islands may
help to mitigate patient costs. A small financial incen-
tive has been part of the Global Fund TB grant in
the Solomon Islands for a number of years. However,
there have been problems with operationalising this
scheme and it may now be timely to revisit the rea-
sons for this and propose a workable solution. The
cost of TB care also has an impact on families and
given the system of family responsibility in Solomon
Islands as part of the wantok system, [28] a kinship
network where caring for one’s relatives is extremely
important, the impact of TB on families (especially
poor ones) should be recognised. In addition, over
the longer term any social or financial protection
schemes should be inclusive of TB patients and future
models of TB care should recognise the costs of care
as a factor in their planning.
Table 6 Coping mechanisms, social consequences, perceived financial impact and social support reported by patients who
participated in the Solomon Islands tuberculosis patient cost survey: 2017–2019
Category Extra-pulmonary TB










Dissavings 2 (5.6) 15 (10.2) 17 (9.3) 0.389
Took out a loan 3 (8.3) 17 (11.6) 20 (10.9) 0.578
Sold assets 0 (0.0) 6 (4.1) 6 (3.3) 0.218
Any of the above 5 (13.9) 31 (21.1) 36 (19.7) 0.330
Social consequences
Social exclusion 2 (5.6) 12 (8.2) 14 (7.7) 0.598
Food insecurity 7 (19.4) 38 (25.9) 45 (24.6) 0.424
Job loss 5 (13.9) 10 (6.8) 15 (8.2) 0.165
Interrupted schooling 7 (19.4) 32 (21.8) 39 (21.3) 0.760
Divorce 0 (0.0) 1 (0.7) 1 (0.5) 0.620
Any of the above 20 (55.6) 79 (53.7) 99 (54.1) 0.845
Perceived financial impact
No impact 1 (2.8) 0 (0.0) 1 (0.5) 0.205
Little impact 3 (8.3) 26 (17.7) 29 (15.8)
Moderate impact 14 (38.9) 54 (36.7) 68 (37.2)
Serious impact 14 (38.9) 50 (34.0) 64 (35.0)
Very serious impact 4 (11.1) 17 (11.6) 21 (11.5)
Social support
From family or relatives 1 (50.0) 6 (85.7) 7 (77.8) 0.284
From a Member of Parliament 1 (50.0) 1 (14.3) 2(22.2)
Total (proportion of all patients) 2 (5.6%) 7 (4.8) 9 (4.9) 0.844
Receipt of vouchers
Food support 16 (100.0) 47 (94.0) 63 (95.5) 0.605
Travel voucher 0 (0) 1 (2.0) 1 (1.5)
Unknown type 0 (0) 2 (4.0) 2 (3.0)
Total (proportion of all patients) 16 (44.4) 50 (34.0) 66 (36.1) 0.243
Abbreviation: TB Tuberculosis
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Conclusion
Tuberculosis is a financially disabling condition in Solo-
mon Islands. Non-medical costs and loss of income are
the main cost drivers. TB patients had very little access
to social or financial protection and not being in the
wealthiest wealth quintile was associated with cata-
strophic costs. In the longer term access to social and fi-
nancial protection may protect patients against the costs
of TB care. However, in the shorter term the NTLP may
want to consider the provision of vouchers to TB pa-
tients and their families while longer term measures
such as the advancement of universal health coverage
and other social and financial protection measures are
pursued.
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